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Background: The most suitable setting of rehabilitation for Persons with Multiple Sclerosis (PwMS) has not been
identified so far because there is a general lacking of controlled studies. Aim of this study was to evaluate the
treatment efficacy in terms of functional independence between two different settings.
Methods: A randomized, wait-list controlled study was performed at the MS Center of the University of Catania,
and Rehabilitation Center of the Hospital of Acireale, Italy. Inclusion criteria were: a) range of age 18–75, b) Expanded
Disability Status Scale ≥4.0 and ≤8.0 c) self-reported worsening of standing or walking abilities in the last 6 months.
The examining physician was blind to patient allocation program. The Functional Independence Measure (FIM), and
the 36-Health Survey Questionnaire (SF-36) data were collected at T0 (baseline) and T1 (follow-up).
Results: One-hundred forty-six patients were randomly assigned to three groups. Forty-nine PwMS were allocated in
the outpatient treatment group (Group A), 49 patients in the inpatients treatment group (Group B) and 48 patients in
the control waiting list (Group C).
Both Group A and Group B showed a significant improvement in total FIM scores (p = 0.03, p = 0.008; respectively) at
T1 compared to T0. No difference was found between Group A and B with regard to the FIM scores in the intergroup
analysis. Group A showed significant improvement at T1 compared to T0 in all sub-items of SF-36 (p < 0.05), contrary
to Group B. A significant difference in total FIM score between the three groups was found (p = 0.0003). The pairwise
comparisons showed a significant difference between Group A vs Group C (p = 0.003) and Group B versus Group C
(p = 0.001).
Conclusions: Inpatients and oupatients rehabilitation approaches both showed efficacy in improving total FIM score.
Outpatient rehabilitation setting seems to be more effective in improving patients QoL.
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Physical rehabilitation is generally accepted as useful for
persons with MS (pwMS). A wide range of rehabilitation
approaches is employed, ranging from more traditional
strategies to newer techniques emphasizing the learning
and practice of functional motor skills within a “task-
specific” context [1, 2]. It is also important to identifyCorrespondence: patti@unict.it
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mine how long the effects last, estimating the cost-
effectiveness. Studies verifying the efficacy of physical
rehabilitation require reliable, valid, and practical out-
come measures. Functional independence and health-
related quality of life (HRQoL) are among the outcome
measures more investigated. Some studies showed as re-
habilitation can improve the motor parameters of func-
tional independence measures (FIM) in PwMS [3–7].
However, the clinical trials performed so far, focusing on
different rehabilitation approaches have showed some
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drugs, quantitative and qualitative disparity of rehabili-
tation treatment, lacking of appropriate and sensitive
outcome instruments are all limits in performing a re-
habilitative clinical trials. All of these factors can strongly
influence the setting, the development and the outcomes
of a rehabilitation program in clinical practice.
To date, four possible options of rehabilitation’s setting
are described in clinical practice: home-based therapy, out-
patient ambulatory therapy, inpatient hospital-based ther-
apy and outpatient hospital-based therapy [3–5, 8–20].
However, guidelines addressing the clinicians to the
rational allocation of PwMS in a specific rehabilitative
program are lacking.
Aim of our study is to investigate the treatment
efficacy in terms of FIM scores between inpatient and
outpatient neurorehabilitation programs. Furthermore, we
evaluated the effects of two different settings of rehabilita-
tion on quality of life.Methods
A randomized, wait-list controlled study was performed
at the MS Center of the University of Catania, Italy and,
at the Rehabilitation Center of the S. Marta & S. Venera
Hospital in Acireale, Catania, Italy. The formal plan of
the study was approved by the local Ethics Committee
in September 2007. All enrolled PwMS signed a written
informed consent.
A total of 260 pwMS, consecutively admitted to MS
Center from 1st January to 30th June 2008, were
screened for the inclusion and exclusion criteria. All
the PwMS suffered by a clinically defined MS according
to 2005 revisions to the McDonald diagnostic criteria
[21]. The required inclusion criteria were: a) range of
age between 18–75, b) disability status assessed by
Expanded Disability Status Scale (EDSS) [22] ≥4.0 and
≤8.0, c) self-reported worsening of standing or walking
abilities for at least 6 months.
Exclusion criteria were: a) PwMS with a diagnosis of MS
less than six months; b) history of recent (<3 months)
disease relapse; c) recent (<6 months) admission to MS-
specific hospital-based rehabilitation; d) presence of cogni-
tive deficits (Mini Mental State Examination-MMSE <24)
[23]; presence of depressive symptoms (Beck Depression
Inventory-BDI >11) [24]; e) severe heart or lung disease;
drug or alcohol abuse; any other illness that could have
excluded the participation in the study. PwMS were moni-
tored along the study period for any neurological and
other medical complications. Experiencing a relapse dur-
ing the study period was considered criteria for dropping
out.
Randomization was performed using a computer
generated sequence at MS center in Catania. Therandomization was stratified according to gender,
age, EDSS score. The treating physician in charge of
the rehabilitation project invited the PwMS to par-
ticipate in the study and explained the rehabilitative
intervention.
The examining physician, blind to patient allocation
program, assessed each PwMS at baseline (T0) and at
last day of rehabilitation period (T1). Both T0 and T1
were performed at the MS Center of the University of
Catania. Both in-and-outpatient, just discharged from
the rehabilitation hospital, went to MS Center to per-
form T1-evaluation; soon after they returned home. In
Group C, T1-evaluation was carried out 40 days after
T0.
EDSS, FIM [25] and 36-Health Survey Questionnaire
(SF-36) [26] were administered as outcome measures.
The PwMS were randomly assigned to three different
groups: Group A, outpatients rehabilitation treatment,
Group B, inpatients rehabilitation treatment and Group
C, no rehabilitation treatment (PwMS in waiting list of
rehabilitation treatment).
In Group A, rehabilitative treatment was performed
once daily, six days per week, for five consecutive weeks.
Overall, PwMs received 30 sessions of treatment. Every
session lasted at least 60 min, as described elsewhere
(4,12). PwMS reached the Rehabilitation Center by car
or public transport.
In Group B rehabilitation treatment was performed
twice-daily, for six days per week. The period of treat-
ment was 35 days. Overall, PwMS received 60 sessions
of treatment. Every session lasted at least 60 min.
Rehabilitation treatment for both groups was performed
at the Rehabilitation Center of the S. Marta & S. Venera
Hospital in Acireale. Patients were not allowed to come
back home on the day without rehabilitative treatment.
Group C included PwMS in a waiting list (between 4
and 6 months for being involved in an inpatient or an
outpatient setting).
The rehabilitative team was composed by 13 re-
habilitation therapists. All therapists were specialized
in neurological rehabilitation and had 5 to 10 years of
work experience.
The study ended in June 2009.
Rehabilitation program
The aim of rehabilitation program was to address motor,
sensor, balance, strength, sphincter functions whether
present; specific physiotherapy sessions, languages or
swallowing or pelvic rehab were administered for at least
4 days a week; pelvic or speech one day a week; finally
one day a week all patients were treated with a global
therapy approach consisting of five sessions. The re-
habilitative treatment was tailored to the specific individ-
ual needs and was planned on volitional tasks mainly
Table 1 Randomized patients’ clinical and demographic
characteristics
Group A Group B Group C p
Number-N. of pts 49 49 48
N. Male (%) 18 (37) 17 (35) 18 (37) No significant
-ns
N. Women (%) 31 (63) 32 (65) 30 (62) ns















31 (63) 32(65) 30 (62) ns
Primary-Progressive
N. (%)
18 (37) 17(35) 18 (37) ns
Mean ± sd EDSS 6.5 ± 1.0 6.5 ± 1.1 6.4 ± 0.6 ns
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the assertion that potential changes are specific to a
given task and not a general effect of any training
[27, 28]. PwMS were treated according to a protocol
based on voluntary exercises for neuromuscular con-
trol, aimed to improve muscle strength of both upper
and lower limbs, propioceptive sensibility, stability and co-
ordination for balance. These exercises were mainly task-
oriented and aimed to ameliorate the activities of daily
living. More in details, we set up a protocol of treatment,
which was identical in the two treated groups. In the first
thirty minutes of each daily session, every PwMS was
asked setting a table, screwing a cap on a bottle, sweeping
a table, binding and untying some laces, and creating
objects with clay. In the subsequent fifteen minutes,
PwMS performed some non-task oriented exercises in-
cluding: catching wooden cubes of different sizes, building
geometric shapes with cubes and grabbing moving objects.
In the last fifteen minutes of each session, all pwMS
underwent a specific training of locomotion and exercises
facilitating the elicitation of postural adjustments for static
and dynamic balance. The examining physician avoided to
discuss any issue related to the rehabilitative treatment
setting.
Primary outcome
The primary outcome was to evaluate the difference in
FIM score between T0 and T1 in groups A and B. To
detect a 20 % difference between time-point, 146 PwMS
entered this parallel-design study. The probability is 99
percent that the study will detect a treatment difference at
a two-sided 0.05 significance level, if the true difference
between treatments is 0.842 times the standard deviation.
Statistical analysis
PwMS was defined as a responder to rehabilitation treat-
ment if she/he showed a 20 % improvement in T1 total
FIM score compared to T0.
Quantitative variables were described using mean and
standard deviation, categorical variable were described
by proportions. To assess the change in total FIM score,
Motor FIM subitems score, Cognitive FIM subitems
score between groups, we calculated the delta value by
subtracting T0 pre-treatment score from T1 score.
Data were analyzed using STATA 10.0 software pack-
ages. A p value < 0.05 was considered as statistically
significant. The difference between means and the differ-
ence between proportions was evaluated by the t-test
and the Fisher exact test respectively. In case of not a
normal distribution appropriate non-parametric tests
were performed. ANOVA with a Bonferroni correction
for multiple comparison was performed to assess the
differences between groups. Mann–Whitney was per-
formed to assess the difference between time-points.Results
Out of the 260 screened PwMS, 114 were not enrolled,
because 59 did not satisfy inclusion criteria, 40 refused
to participate and 15 lived far away from the rehabilita-
tion center (a long distance to the Rehabilitation Center
was arbitrarily considered a disadvantage to be enrolled
in the study). Thus, 146 PwMS were included and ran-
domized using a computer generated sequence.
Forty-nine were allocated in the Rehabilitation Outpa-
tients Treatment (Group A); 49 in the Rehabilitation
Inpatient Treatment (Group B) and 48 in Control Wait-
ing List (Group C). Baseline demographic and clinical
characteristics of the 146 enrolled PwMS are summa-
rized in Table 1. There were not significant differences
among the three groups for all variables. All randomized
PwMS completed the study and were analyzed. No
drop-outs were observed for any of the three groups of
the study.
Total FIM score improved in 22.6 % of patient in
group A and 14.6 % in group B (p = 0.5). Motor FIM
subitems improved in 32 % of patients in group A and
21.4 % in group B (p = 0.4) while cognitive FIM subitems
showed no improvement in group A and an improve-
ment in 3.5 % of patients in group B.
Intragroup analysis
We found a significant difference in term of total FIM
score between T0 and T1 in Group A (91 ± 9.9 vs 98.6
± 15.2, p = 0.03), in Group B (89.4 ± 20 vs 98.3 ± 17.3,
p = 0.008) and Motor FIM subitems score in Group A
(59 ± 9.4 vs 66 ± 13.4, p = 0.02) (Table 2). In Group C,
was found no significant variation between T0 and
T1in terms of total FIM scores and its subitems.
Variations of SF-36 domains are presented in Table 3.
Significant differences were observed at T1 compared to
Table 2 Comparison of FIM total score; motor and cognitive sub-items between T0 and T1 in three groups














Total FIM 91 ± 9.9 98.6 ± 15.2 0.03 89.4 ± 20 98.3 ± 17.3 0.008 89.5 ± 15.9 89.3 ± 15.9 ns
Motor subtotal score 59 ± 9.4 66 ± 13.4 0.02 59 ± 18.5 67 ± 16.1 0.09 58 ± 12.8 58 ± 12.9 ns
Cognitive subtotal score 32 ± 2.8 32 ± 2.4 ns 31 ± 3.8 32 ± 3.4 ns 31.5 ± 4.5 31 ± 4.5 ns
Mann–Whitney test was performed between T0 and T1
Pappalardo et al. Multiple Sclerosis and Demyelinating Disorders  (2016) 1:3 Page 4 of 7T0 only in Group A. In particular, the most significant
change was found in physical role functioning (31.8 ±
34.8 vs 55 ± 42.9, p < 0.0001), vitality (46.7 ± 16.8 vs
58.4 ± 15.1, p < 0.0001), social role functioning (56.6 ±
22.1 vs 76.7 ± 18.7, p < 0.0001) and mental health (54.4 ±
18.5 vs 64.8 ± 17.3, p < 0.0001).
Intergroup analysis
Delta values of total FIM score, motor FIM subitems
score and cognitive FIM subitems score were compared
between the three groups (group A, group B, group C).
A significant difference in total FIM score between the
three groups was found (p = 0.0003). When the pairwise
comparisons were investigated, we found a significant
difference between Group A vs Group C (p = 0.003) and
Group B versus Group C (p = 0.001). Motor FIM subi-
tems score was significantly different between groups
(p = 0.0001). The pairwise comparison showed a signifi-
cant difference between Group A versus Group C (p <
0.001) and in Group B versus Group C (p < 0.001). No
significant differences in cognitive FIM subitems scores
were observed between the three groups (see Table 4).
Discussion
The results of this randomized study showed significant
and clinically meaningful changes in term of impact on
the functional independence inpatient and outpatient







Physical function 31.2 ± 20.7 37.8 ± 28 p < 0.05
Physical role functioning 31.8 ± 34.8 55 ± 42.9 p < 0.0001
Bodily pain 52.7 ± 25.8 67.2 ± 23.8 p < 0.001
General health perceptions 48.8 ± 19.6 52.5 ± 19.2 p < 0.001
Vitality 46.7 ± 16.8 58.4 ± 15.1 p < 0.0001
Social role functioning 56.6 ± 22.1 76.7 ± 18.7 p < 0.0001
Emotional role functioning 60.8 ± 39.6 73.1 ± 34.6 p < 0.05
Mental health 54.4 ± 18.5 64.8 ± 17.3 p < 0.0001
p < 0.05 - Wilcoxon signed rank for Group A versus both Group B and Group Cparticular, the subcategories of motor FIM demonstrated
higher improvement compared to the other subcat-
egories, showing as PwMS can gain benefits in their
daily-living activities as well as in their mobility. The
improvement of motor FIM was found in 32 and 21.4 %
of patients respectively in Group A and B. These percent-
ages, although not high, were obtained as we defined a
patient as responder to rehabilitation whether he/she
showed a 20 % improvement in T1 compared to T0. We
choose a low cut-off in order to more spot the potential of
neurorehabilitation in PwMS.
The efficacy of rehabilitation in PwMS was just de-
scribed elsewhere [3, 4, 8–20, 29–34].
A Cochrane review including 260 patients showed
strong evidence for exercise therapy compared to no
exercise therapy in terms of muscle power function,
exercise tolerance functions and mobility-related activ-
ities [30]. A recent systematic review including 54 stud-
ies, found strong evidence that exercise performed two
times per week increases aerobic capacity and muscular
strength, whereas the evidence was not consistent re-
garding the effects of exercise training on mobility, fa-
tigue, and health-related quality of life [29].
Over the past 20 years, numerous studies have been
published that for the design, number of enrolled pa-
tients, outcome measures, rehabilitative strategy and set-
ting; that is studies performed in inpatient, outpatient
and home-based rehabilitation. Inpatient setting wasand T1










25.8 ± 19.1 26.6 ± 20.2 ns 23.5 ± 15.5 24.4 ± 17.7 ns
30 ± 22 31.4 ± 18.5 ns 31.2 ± 37 28.4 ± 35.3 ns
62.9 ± 28.2 67.5 ± 26.9 ns 64.4 ± 28.6 63.1 ± 28.4 ns
44.6 ± 17.8 49.5 ± 20.5 ns 51 ± 20.2 50.2 ± 19.5 ns
41.2 ± 16.7 43 ± 18.8 ns 48.5 ± 20.1 46.2 ± 18.3 ns
62.9 ± 22.8 64 ± 26.2 ns 60.8 ± 25.8 59 ± 25 ns
48.8 ± 41.1 49.6 ± 38.3 ns 45.3 ± 43.6 44.3 ± 43.5 ns
62 ± 25.5 67 ± 23.5 ns 59 ± 26.1 56.9 ± 24.9 ns
Table 4 Delta value between three groups
Variables Group A Group B Group C p
Total FIM 8 ± 12 8,9 ± 9,7 −0,2 ± 0,6 0.0003*
Motor subtotal score 8 ± 9,5 8 ± 9,2 0 ± 0,7 0.0001**
Cognitive subtotal score 0 ± 3,1 0,7 ± 1,3 0 0.3053
*Bonferroni Correction: Group A vs Group C p = 0.003; Group B vs Group C
p = 0.001; Group A vs Group B ns
**Bonferroni Correction: Group A vs Group C p < 0.001; Group B vs Group C
p < 0.001; Group A vs Group B ns
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impairment [15], disability [10, 32], functional independ-
ence [3] and HRQoL [3, 10, 32]. Trials conducted in out-
patient setting demonstrated effectiveness of rehabilitation
in improvement of muscular strength (9), walking capacity
[34], functional independence [4], HRQol [9, 11, 12, 34].
Home-based rehabilitation showed significant improve-
ment in HRQoL [13, 16], balance [17, 19], leg extensor
power [14], gait parameters [20], fatigue [10].
Very recently, an exercise-based patient education pro-
gram conducted at home or at outpatient set, demon-
strated improvements in PwMS’ mobility, gait ability,
endurance, fatigue, and health-related quality of life after
completing the 12-week intervention [31].
As exposed in the introduction, we searched to ad-
dress an unresolved question in MS clinical practice:
what is the most suitable setting for PwMS? This issue is
becoming crucial, considering that the majority of MS
patients required rehabilitation treatment [35] and that
leads to increasing health costs [36]. To the best of our
knowledge, only few studies were designed considering a
comparison between two different settings of rehabilita-
tion (outpatient versus inpatient). Francabandera et al.
[8] reported that inpatient rehabilitation resulted in
small but significant improvements in ambulatory status
and level of independence in self-care as compared
with outpatient treatment. But that study enrolled
PwMS with a more severe disability (EDSS score 6.0
– 9.0) than ours and the outpatient group received
physical and occupational therapy not only i a clinic
but also at home; therefore a comparison with our
work is difficult to perform.
In a more recent randomized study [5], both in-and
–outpatient PwMS showed statistically significant im-
provement in FIM total score and in the FIM motor
domains compared to controls; whereby the rehabili-
tation programme for PwMS determined important
reduction in disability with a large treatment effect
sizes for a number of FIM domains. In that study,
unlike ours, the authors also enrolled PwMS affected
by the Relapsing-Remitting phenotype; beside, they
did not separately provide the data of the two setting
of rehabilitation, as the objectives of that study were
different from those of our study.Traditionally, rehabilitation has been targeted at main-
taining and preserving patient’s personal and social ac-
tivities. The findings of our study, as well as those of
others studies, advice us that the goals of neurorehabil-
itation should be renewed, targeting to the improvement
of the residual capacities and so, enhancing the func-
tional independence. To this aim, we believe that active
rehabilitation, based on voluntary task-oriented exer-
cises, could determine beneficial effects in terms of func-
tional independence. In agreement with this assertion,
Bonzano et al. demonstrated that rehabilitation treat-
ment based on voluntary movements may contribute to
preserve the white matter integrity in the corpus callo-
sum and corticospinal tracts and to maintain the coord-
ination ability; such benefits were not observed in
control group [27]. These findings confirms the hypoth-
esis that the sensorimotor deficits observed in PwMS
over the disease course could be mainly due to the
progression of white matter damage and that neuror-
ehabilitation may attenuate this neurodegenerative
process [37, 38].
In our study, just Group A showed a significant im-
provement social and psychological parameters in SF-36.
In Group B, we found a slight but not statistically signifi-
cant improvement in all domains of SF-36. Some years
ago, other authors were reached to the same finding;
inpatient treated group improved in functional impair-
ment but not in HRQoL [15]. Therefore, the lack of
efficacy on HRQoL in Group B might be related to the
hospitalization, which could have determined a greater
psychological stressful effect and we sought to screen
that in the future. To the outpatients were offered the
possibility to came back home after every treatment
session, and therefore, they could continue their jobs
and their social activities. That support the evidence of
the most meaningful benefit in QoL domain social role
functioning for these PwMS.
These findings may draw the conclusion that a differ-
ent setting for rehabilitation treatment should be chosen
taking into account many personal needs and desires of
each patient. A physician dealing with a rehabilitative
treatment should bear in mind the emotional aspects in
PwMS to come back home at the end of each daily
session. A recent study showed that PwMS had less
functional improvement than other populations using
the inpatient rehabilitation setting and the higher rates
of depression was found within the MS population [39].
This finding must be an important consideration for
rehabilitation service needs in PwMS.
The willingness and the economic possibilities of the
patients to get the rehabilitative center every day have to
be considered as well their wishes of improvement.
However, which is the real impact of the hospitalization
on the previous habitual activities of the patient’s daily
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and psychological profile?
Nowadays it is very important the economic costs and
relative cost-effectiveness of the different rehabilitative
settings [36]. There is no doubt that outpatient rehabili-
tation is less expensive than the inpatient rehabilitation
program, independently from the comparable effective-
ness. At the same time, outpatient rehabilitation seems
to be more burdensome for patients in terms of eco-
nomic resources and familiar commitment (travel cost,
caregiver time management, etc.).
We are aware about the limitations of our study. A per-
centage of about 45 % of PWMS were nor enrolled and
only patients with an EDSS ≥4.0 and ≤8.0 were recruited.
That cannot generalize our results to a global MS popula-
tion. However, the three groups had comparable baseline
characteristics and adequate cognitive performing that
allowed to reduce a major source of bias. Moreover, we did
not perform follow-up assessment, but we aimed to set an-
other study to ride over these limitations and to evaluate
the eventual carry-on effects of both rehabilitation settings.
Despite the above limitations, we found that both
rehabilitative treatment settings, inpatient and out-
patient, are equally effective in diminishing the disability
in PwMs. Interestingly, only the outpatient treatment
was found to be effective in improving the HRQoL.
Conclusions
In conclusion, we believe that outpatient setting is usually
well accepted by PwMS with minimal impact on patients
habitual familiar and social life. However it should be
underlined that inpatient setting could be more suitable
for both patients with a more severe disability that have
difficulties in terms of reaching the rehabilitative center
and for those preferring to be treated without involvement
of relatives or caregivers. More studies needed.
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